Upregulation of toll-like receptor 4 on T cells in PBMCs is associated with disease aggravation of HBV-related acute-on-chronic liver failure.
10.1007/s11596-015-1527-x
- Author:
Chun-li XU
1
;
You-hua HAO
2
;
Yin-ping LU
3
;
Zong-sheng TANG
3
;
Xue-cheng YANG
3
;
Jun WU
3
;
Xin ZHENG
3
;
Bao-ju WANG
3
;
Jia LIU
4
;
Dong-liang YANG
5
Author Information
1. Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. 290398030@qq.com.
2. Division of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
3. Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
4. Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. dlyang@mail.hust.edu.cn.
5. Department of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. jialiu77@hotmail.com.
- Publication Type:Journal Article
- Keywords:
chronic hepatitis B;
hepatitis B-related acute-on-chronic liver failure;
peripheral blood mononuclear cells;
toll-like receptor
- MeSH:
Adult;
End Stage Liver Disease;
metabolism;
virology;
Female;
Hepatitis B virus;
pathogenicity;
Humans;
Male;
Middle Aged;
Monocytes;
metabolism;
RNA, Messenger;
genetics;
T-Lymphocytes;
metabolism;
Toll-Like Receptor 4;
genetics;
metabolism;
Up-Regulation
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2015;35(6):910-915
- CountryChina
- Language:English
-
Abstract:
Immune-mediated inflammatory injury is an important feature of the disease aggravation of hepatitis B virus-related acute-on-chronic liver failure (ACLF). Toll-like receptors (TLRs) have been shown previously to play a pivotal role in the activation of innate immunity. The purpose of this study was to characterize the TLR4 expression in peripheral blood mononuclear cells (PBMCs) of ACLF patients and its possible role in the disease aggravation. Twelve healthy subjects, 15 chronic HBV-infected (CHB) patients and 15 ACLF patients were enrolled in this study. The TLR4 expression in PBMCs and T cells of all subjects was examined by real-time PCR and flow cytometry. The correlation of TLR4 expression on T cells with the markers of disease aggravation was evaluated in ACLF patients. The ability of TLR4 ligands stimulation to induce inflammatory cytokine production in ACLF patients was analyzed by flow cytometry. The results showed that TLR4 mRNA level was upregulated in PBMCs of ACLF patients compared to that in the healthy subjects and the CHB patients. Specifically, the expression of TLR4 on CD4(+) and CD8(+) T cells of PBMCs was significantly increased in ACLF patients. The TLR4 levels on CD4(+) and CD8(+) T cells were positively correlated with serum total bilirubin (TBIL), direct bilirubin (DBIL), international normalized ratio (INR) levels and white blood cells (WBCs), and negatively correlated with serum albumin (ALB) levels in the HBV-infected patients, indicating TLR4 pathway may play a role in the disease aggravation of ACLF. In vitro TLR4 ligand stimulation on PBMCs of ACLF patients induced a strong TNF-α production by CD4(+) T cells, which was also positively correlated with the serum markers for liver injury severity. It was concluded that TLR4 expression is upregulated on T cells in PBMCs, which is associated with the aggravation of ACLF.
